Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT. - Université de Lille
Article Dans Une Revue HemaSphere Année : 2023

Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT.

Didier Blaise
Edouard Forcade
  • Fonction : Auteur

Dates et versions

hal-04481672 , version 1 (28-02-2024)

Identifiants

Citer

Marie Robin, Liesbeth C. de Wreede, Thomas Schroeder, Friedrich Stölzel, Nicolaus Kröger, et al.. Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT.. HemaSphere, 2023, HemaSphere, 7, pp.e851. ⟨10.1097/HS9.0000000000000851⟩. ⟨hal-04481672⟩
9 Consultations
0 Téléchargements

Altmetric

Partager

More